| REGENERON PHARMACEUTICALS |
| USA |
| Gesundheit |
| US75886F1075 / 881535 |
| RGO (Frankfurt) / REGN (NASDAQ) |
| FRA:RGO, ETR:RGO, RGO:GR, NASDAQ:REGN |
| https://www.regeneron.com.. |
|
Regeneron Pharmaceuticals, Inc. is a biotechnology company focused on discovering, developing, and commercializing medicines for serious diseases across eye care, immunology, oncology, cardiovascular health, and inflammation. Its current portfolio in..
>Volltext.. |
| 63264.4 Mio. EUR |
| 58051.82 Mio. EUR |
| 12946.32 Mio. EUR |
| 3803.13 Mio. EUR |
| 3838.36 Mio. EUR |
| 36.91 EUR |
| 2348.28 Mio. EUR |
| 2577.71 Mio. EUR |
| 4349.72 Mio. EUR |
| 1.72 |
| -0.82% |
| -7.94% |
| 3.12 EUR |
| 0.52% |
| 0.53% |
| 20.05.26 - 0.808306€ 20.02.26 - 0.798906€ >weitere anzeigen... |
| REGENERON |
| 31.07.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|